Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2007; 13(48): 6593-6597
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6593
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6593
Table 4 Follow-up results of RBC counts (× 1012/L)
Time | Group A | Group B | P-value2 | ||
mean ± SD | P-value1 | mean ± SD | P-value1 | ||
Pre-treatment | 3.02 ± 0.49 | 3.07 ± 0.51 | 0.75 | ||
Post-treatment | |||||
1 wk | 2.84 ± 0.72 | 0.297 | 2.93 ± 0.56 | 0.375 | 0.639 |
2 wk | 2.88 ± 0.54 | 0.325 | 2.97 ± 0.68 | 0.583 | 0.606 |
1 mo | 2.81 ± 0.36 | 0.073 | 2.93 ± 0.71 | 0.442 | 0.430 |
2 mo | 2.92 ± 0.42 | 0.418 | 2.85 ± 0.62 | 0.185 | 0.623 |
3 mo | 3.04 ± 0.50 | 0.924 | 2.97 ± 0.47 | 0.439 | 0.644 |
- Citation: Huang JH, Gao F, Gu YK, Li WQ, Lu LW. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol 2007; 13(48): 6593-6597
- URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6593.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6593